Literature DB >> 25028382

Are rheumatoid arthritis patients discernible from other early arthritis patients using 1.5T extremity magnetic resonance imaging? a large cross-sectional study.

Wouter Stomp1, Annemarie Krabben2, Désirée van der Heijde2, Tom W J Huizinga2, Johan L Bloem2, Annette H M van der Helm-van Mil2, Monique Reijnierse2.   

Abstract

OBJECTIVE: Magnetic resonance imaging (MRI) is increasingly used in rheumatoid arthritis (RA) research. A European League Against Rheumatism (EULAR) task force recently suggested that MRI can improve the certainty of RA diagnosis. Because this recommendation may reflect a tendency to use MRI in daily practice, thorough studies on the value of MRI are required. Thus far no large studies have evaluated the accuracy of MRI to differentiate early RA from other patients with early arthritis. We performed a large cross-sectional study to determine whether patients who are clinically classified with RA differ in MRI features compared to patients with other diagnoses.
METHODS: In our study, 179 patients presenting with early arthritis (median symptom duration 15.4 weeks) underwent 1.5T extremity MRI of unilateral wrist, metacarpophalangeal, and metatarsophalangeal joints according to our arthritis protocol, the foot without contrast. Images were scored according to OMERACT Rheumatoid Arthritis Magnetic Resonance Imaging Scoring (RAMRIS) by 2 independent readers. Tenosynovitis was also assessed. The main outcome was fulfilling the 1987 American College of Rheumatology (ACR) criteria for RA. Test characteristics and areas under the receiver-operator-characteristic curves (AUC) were evaluated. In subanalyses, the 2010 ACR/EULAR criteria were used as outcome, and analyses were stratified for anticitrullinated protein antibodies (ACPA).
RESULTS: The ACR 1987 criteria were fulfilled in 43 patients (24.0%). Patients with RA had higher scores for synovitis, tenosynovitis, and bone marrow edema (BME) than patients without RA (p < 0.05). ACPA-positive patients had more BME (median scores 6.5 vs. 4.25, p = 0.016) than ACPA-negative patients. For all MRI features, the predictive value for the presence of RA was low (< 50%). For all MRI features the AUC were < 0.70. Patients who fulfilled ACR/EULAR 2010 criteria but not ACR87 criteria for RA had less synovitis than patients who were positive for RA according to both sets of criteria (p = 0.029).
CONCLUSION: Although patients with RA had higher scores of MRI inflammation and ACPA-positive patients had more BME, the severity of MRI inflammation assessed according to RAMRIS does not accurately differentiate patients with RA from other early arthritis patients.

Entities:  

Keywords:  ARTHRITIS; MAGNETIC RESONANCE IMAGING; METACARPUS; METATARSUS; RHEUMATOID ARTHRITIS; WRIST

Mesh:

Substances:

Year:  2014        PMID: 25028382     DOI: 10.3899/jrheum.131169

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  5 in total

1.  Aiming for a simpler early arthritis MRI protocol: can Gd contrast administration be eliminated?

Authors:  Wouter Stomp; Annemarie Krabben; Désirée van der Heijde; Tom W J Huizinga; Johan L Bloem; Mikkel Østergaard; Annette H M van der Helm-van Mil; Monique Reijnierse
Journal:  Eur Radiol       Date:  2015-01-31       Impact factor: 5.315

2.  MRI-detected osteitis is not associated with the presence or level of ACPA alone, but with the combined presence of ACPA and RF.

Authors:  Debbie M Boeters; Wouter P Nieuwenhuis; Marije K Verheul; Elize C Newsum; Monique Reijnierse; René E M Toes; Leendert A Trouw; Annette H M van der Helm-van Mil
Journal:  Arthritis Res Ther       Date:  2016-08-02       Impact factor: 5.156

3.  Diagnostic value of a 3-day course of prednisolone in patients with possible rheumatoid arthritis - the TryCort study.

Authors:  Uta Kiltz; Christine von Zabern; Xenofon Baraliakos; Frank Heldmann; Bernd Mintrop; Michael Sarholz; Dietmar Krause; Friedrich Dybowski; Ludwig Kalthoff; Jürgen Braun
Journal:  Arthritis Res Ther       Date:  2017-04-07       Impact factor: 5.156

Review 4.  Clinical utility of eco-color-power Doppler ultrasonography and contrast enhanced magnetic resonance imaging for interpretation and quantification of joint synovitis: a review.

Authors:  Marina Carotti; Vittoria Galeazzi; Francesca Catucci; Marcello Zappia; Francesco Arrigoni; Antonio Barile; Andrea Giovagnoni
Journal:  Acta Biomed       Date:  2018-01-19

5.  Rheumatoid arthritis: what do MRI and ultrasound show.

Authors:  Iwona Sudoł-Szopińska; Lennart Jans; James Teh
Journal:  J Ultrason       Date:  2017-03-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.